SETD2 and nonpapillary renal cell carcinoma: Additionally, we found that the mutation of SETD2 and PRKDC was more likely to occur in the high-risk group (Figure 7C), but the mutation of SETD2 and PRKDC was not associated with prognosis in ccRCC (Figures 7D, E).